当前位置:首页 - 行情中心 - 莱茵生物(002166) - 财务分析 - 现金流量表

莱茵生物

(002166)

  

流通市值:63.59亿  总市值:63.85亿
流通股本:7.39亿   总股本:7.42亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金799,911,260.951,876,945,197.511,486,182,916.971,056,035,394.49
  收到的税费返还19,361,777.9527,124,526.5423,862,794.4120,626,504.66
  收到其他与经营活动有关的现金1,679,892.0825,891,029.848,684,811.596,048,776.05
  经营活动现金流入小计820,952,930.981,929,960,753.891,518,730,522.971,082,710,675.2
  购买商品、接受劳务支付的现金415,874,342.421,409,249,450.65912,762,861.02603,291,753.05
  支付给职工以及为职工支付的现金61,704,628.4199,540,350.79149,746,011.16104,261,122.76
  支付的各项税费17,914,432.7454,753,223.3441,928,622.3134,739,231.06
  支付其他与经营活动有关的现金12,589,334.21106,209,630.3167,835,326.2545,641,368.26
  经营活动现金流出小计508,082,737.771,769,752,655.091,172,272,820.74787,933,475.13
  经营活动产生的现金流量净额312,870,193.21160,208,098.8346,457,702.23294,777,200.07
二、投资活动产生的现金流量:
  收回投资收到的现金246,524.181,011,003.25998,683.5380,839.52
  取得投资收益收到的现金-4,403,059.634,403,059.6315,047.83
  处置固定资产、无形资产和其他长期资产收回的现金净额43,4002,161,880.2136,830.2104,348
  收到的其他与投资活动有关的现金-1,000,000--
  投资活动现金流入小计289,924.188,575,943.085,538,573.33500,235.35
  购建固定资产、无形资产和其他长期资产支付的现金38,501,822.49162,162,280.89120,246,861.4885,226,314.72
  投资活动现金流出小计38,501,822.49162,162,280.89120,246,861.4885,226,314.72
  投资活动产生的现金流量净额-38,211,898.31-153,586,337.81-114,708,288.15-84,726,079.37
三、筹资活动产生的现金流量:
  取得借款收到的现金206,000,0001,340,848,408.5789,848,408.5503,848,408.5
  收到其他与筹资活动有关的现金-12,600,00012,600,000-
  筹资活动现金流入小计206,000,0001,353,448,408.5802,448,408.5503,848,408.5
  偿还债务支付的现金233,648,1971,174,637,456.4789,440,092.5500,010,092.5
  分配股利、利润或偿付利息支付的现金14,246,007.82121,530,331.21103,919,944.5693,938,443.58
  支付其他与筹资活动有关的现金170,307.549,670,744.7653,188,616.4847,245,130.92
  筹资活动现金流出小计248,064,512.321,345,838,532.37946,548,653.54641,193,667
  筹资活动产生的现金流量净额-42,064,512.327,609,876.13-144,100,245.04-137,345,258.5
四、汇率变动对现金及现金等价物的影响-2,144,401.331,150,099.231,492,697.061,563,464.92
五、现金及现金等价物净增加额230,449,381.2515,381,736.3589,141,866.174,269,327.12
  加:期初现金及现金等价物余额65,151,142.749,769,406.3549,769,406.3549,769,406.35
  期末现金及现金等价物余额295,600,523.9565,151,142.7138,911,272.45124,038,733.47
补充资料:
  净利润-152,883,586.27-43,672,421.11
  资产减值准备--1,344,480.6-422,147.6
  固定资产和投资性房地产折旧-122,721,423.88-60,963,155.65
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-122,721,423.88-60,963,155.65
  无形资产摊销-5,036,987.98-2,514,229.17
  长期待摊费用摊销-1,095,257.04-565,772.46
  处置固定资产、无形资产和其他长期资产的损失-129,684.76-109,497.53
  固定资产报废损失-3,361,840.68-942,659.52
  公允价值变动损失--4,246,764.89-207,129.89
  财务费用-42,887,561.83-19,396,828.1
  投资损失--4,600,454.64--74,624.01
  递延所得税-4,557,980.05-2,321,545.33
  其中:递延所得税资产减少-4,472,040.83-872,809.53
    递延所得税负债增加-85,939.22-1,448,735.8
  存货的减少--100,813,264.32-30,610,947.13
  经营性应收项目的减少--258,131,098.79-172,473,105.21
  经营性应付项目的增加-179,671,166.63--39,426,464.42
  其他-13,576,369.23--1,590,905.19
  现金的期末余额-65,151,142.7-124,038,733.47
  减:现金的期初余额-49,769,406.35-49,769,406.35
  现金及现金等价物的净增加额-15,381,736.35-74,269,327.12
公告日期2026-04-302026-03-312025-10-282025-08-29
审计意见(境内)标准无保留意见
TOP↑